• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE VALVE SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE VALVE SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 8300AB
Device Problems Fluid/Blood Leak (1250); Perivalvular Leak (1457); Detachment of Device or Device Component (2907)
Patient Problem Insufficient Information (4580)
Event Date 06/27/2022
Event Type  Injury  
Manufacturer Narrative
Valve dehiscence may occur early or late.When it occurs in the early post-operative period, it is typically a result of an inadequate prosthetic valve implantation in combination with friable myocardial tissue.Late dehiscence can occur as a result of successive dilatation of cardiac structures that result from progression of disease.The device was not returned for evaluation, as device request is ongoing.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
 
Event Description
Through implant patient registry, it was learned that a 23mm aortic valve was explanted after an implant duration of 3 years, 1 month due to severe perivalvular leak with severe eccentric regurgitation secondary to dehiscence.The explanted valve was replaced with a 23mm aortic valve.Per medical records a small pvl was noted on echo a year ago, recent echo showed pvl progressed to severe level.A tee demonstrated evidence of partial dehiscence of the valve with severe eccentric regurgitation from 2 perivalvular jets.The or tee confirmed severe aortic perivalvular regurgitation.Intra-operatively there was dehiscence of the subvalvular cuff from the annulus in the area of the right coronary sinus, leaving a large gap.There was no evidence to suggest infection.A post implant tee demonstrated the 23mm 11500a aortic valve was seated nicely and there was no pvl.The patient was transported to thoracic icu in stable condition and was discharged on pod #1.Pathology of the explanted aortic valve showed no calcification, no cusp tears, no thrombus and no obstructive fibrous ingrowth.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital and patient family members) and is not received in the form of a conventional "customer complaint." the information reported may or may not be related to the edwards device.
 
Manufacturer Narrative
H10: additional narratives.Updated d4, h4, and h6 per new information received.A definitive root cause cannot be conclusively determined; however, patient and/or procedural factors likely caused or contributed.The device history record (dhr) was reviewed and showed that this device met all manufacturing and sterilization specifications for product release prior to distribution.No issues were identified that would have impacted this event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INTUITY ELITE VALVE SYSTEM
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
reginald santos
one edwards way
mailstop anton 6.1
irvine, CA 92614
9492502731
MDR Report Key15300650
MDR Text Key298673218
Report Number2015691-2022-07521
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194494
UDI-Public(01)00690103194494(17)221105
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/05/2022
Device Model Number8300AB
Device Catalogue Number8300AB23A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/02/2022
Initial Date FDA Received08/26/2022
Supplement Dates Manufacturer Received10/05/2022
Supplement Dates FDA Received10/06/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/06/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age62 YR
Patient SexMale
-
-